


The Invesco Perpetual High Income Fund aims to achieve a high level of income, together with capital growth. The fund intends to invest primarily in companies listed in the UK, with the balance invested internationally.
| Name | % Net Assets |
|---|---|
| Novartis | 2.6% |
| Roche | 2.4% |
| Novartis | 1.7% |
| Barclays Bank 14% £ Bonds Perp | 1.6% |
| John Lewis 8.375% £ Bonds 8/4/2019 | 1.5% |
| Carlsberg 7.25% £ Bonds 28/11/2016 | 1.4% |
| GDF Suez | 1.4% |
| ING | 1.1% |
| Sanofi | 1.1% |
| Atlantia | 1.0% |
| Key | % Net Assets |
|---|---|
| 2.6% | |
| 2.4% | |
| 1.7% | |
| 1.6% | |
| 91.7% |
| Date | 19-Aug-2022 |
|---|---|
| NAV | 110.73p |
| Currency | GBP |
| Change | 0.000p |
| % | n/a |
| YTD change | 110.73p |
| YTD % | n/a |
| Fund Inception | 01/05/2008 |
|---|---|
| Fund Manager | n/a |
| TER | 1.51 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.52% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research